A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses

被引:6
作者
Sheizaf, Boaz [1 ]
Sheiner, Eyal [1 ]
Fink, Miriam [1 ]
Hershkovitz, Reli [1 ]
Mazor, Moshe [1 ]
Wiznitzer, Arnon [1 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Div Obstet & Gynecol, IL-84103 Beer Sheva, Israel
关键词
Nuchal translucency; ultrasound; perinatal mortality; diabetes mellitus; obstetric outcomes; CHROMOSOMALLY NORMAL FETUSES; NORMAL KARYOTYPE; MATERNAL AGE; 1ST TRIMESTER; FOLLOW-UP; GESTATION; PREGNANCY; 1ST-TRIMESTER; DEFECTS; POPULATION;
D O I
10.1080/14767050802676717
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. Evaluating the correlation between the nuchal translucency (NT) measurement throughout its range of values independent of gestational age, and adverse pregnancy outcome: in euploid structurally normal fetuses. Methods. A prospective observational study was conducted in which NT measurements were made in consecutive singleton euploid fetuses derived from an unselected pregnant population. Pregnancies terminated before the 22nd gestational week, and those with major malformations (diagnosed before or after delivery) were excluded from the analysis. We evaluated the linear association between NT thickness and selected obstetric outcomes. Results. A total of 2205 euploid singleton fetuses were evaluated during the study period. Significant linear-by-linear association was documented between the NT measurement and perinatal mortality (p<0.001). Thicker NT was significantly associated with diabetes (either gestational or pre-gestational) (p=0.013). Conclusions. A linear association exists between NT thickness in chromosomally and structurally normal fetuses, and the risk for gestational diabetes and perinatal mortality.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 29 条
[1]   The effect of metabolic control on fetal nuchal translucency in women with insulin-dependent diabetes: a preliminary study [J].
Bartha, JL ;
Wood, J ;
Kyle, PM ;
Soothill, PW .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 21 (05) :451-454
[2]   Increased nuchal translucency thickness and normal karyotype:: time for parental reassurance [J].
Bilardo, C. M. ;
Muller, M. A. ;
Pajkrt, E. ;
Clur, S. A. ;
Van Zalen, M. M. ;
Bijlsma, E. K. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2007, 30 (01) :11-18
[3]   Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF) [J].
Brausewetter, F ;
Jehle, PM ;
Jung, MF ;
Boehm, BO ;
Brueckel, J ;
Hombach, V ;
Osterhues, HH .
HORMONE AND METABOLIC RESEARCH, 2001, 33 (12) :713-720
[4]   Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? [J].
Comstock, Christine H. ;
Malone, Fergal D. ;
Ball, Robert H. ;
Nyberg, David A. ;
Saade, Georqe R. ;
Berkowitz, Richard L. ;
Ferreira, Jose ;
Dugoff, Lorraine ;
Craigo, Sabrina D. ;
Timor-Tritsch, Ilan E. ;
Stephen, R. Carr ;
Wolfe, Honor M. ;
Bianchi, Diana W. ;
D'Alton, Mary E. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (03) :843-847
[5]   Pathophysiology of increased nuchal translucency: a review of the literature [J].
Haak, MC ;
van Vugt, JMG .
HUMAN REPRODUCTION UPDATE, 2003, 9 (02) :175-184
[6]   Fetal nuchal translucency and normal chromosomes: a long-term follow-up study [J].
Hiippala, A ;
Eronen, M ;
Taipale, P ;
Salonen, R ;
Hiilesmaa, V .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (01) :18-22
[7]   Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study [J].
Hyett, J ;
Perdu, M ;
Sharland, G ;
Snijders, R ;
Nicolaides, KH .
BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :81-85
[8]   Relation between increased fetal nuchal translucency thickness and chromosomal defects [J].
Kagan, KO ;
Avgidou, K ;
Molina, FS ;
Gajewska, K ;
Nicolaides, KH .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :6-10
[9]  
Kelekci S, 2005, J Obstet Gynaecol, V25, P579, DOI 10.1080/01443610500231518
[10]   First-trimester nuchal translucency screening in pregnant women who subsequently developed gestational diabetes [J].
Leipold, H ;
Worda, C ;
Özbal, A ;
Husslein, P ;
Krampl, E .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (07) :529-532